Thalidomide-O-C7-NH2
Modify Date: 2024-01-11 11:13:04
Thalidomide-O-C7-NH2 structure
|
Common Name | Thalidomide-O-C7-NH2 | ||
|---|---|---|---|---|
| CAS Number | 2093536-11-7 | Molecular Weight | 387.43 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H25N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Thalidomide-O-C7-NH2Thalidomide-O-C7-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
| Name | Thalidomide-O-C7-NH2 |
|---|
| Description | Thalidomide-O-C7-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
|---|---|
| Related Catalog | |
| Target |
Cereblon |
| In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| References |
| Molecular Formula | C20H25N3O5 |
|---|---|
| Molecular Weight | 387.43 |
| Hazard Codes | Xi |
|---|